-
Signature
-
/s/ Christiana Stevenson, Attorney-in-Fact
-
Issuer symbol
-
VRTX
-
Transactions as of
-
01 Jul 2025
-
Net transactions value
-
-$16,767,916
-
Form type
-
4
-
Filing time
-
02 Jul 2025, 16:16:51 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Arbuckle Stuart A |
EVP, COO |
C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON |
/s/ Christiana Stevenson, Attorney-in-Fact |
02 Jul 2025 |
0001557290 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VRTX |
Common Stock |
Tax liability |
$16,767,916 |
-37,243 |
-37% |
$450.23 |
63,368 |
01 Jul 2025 |
Direct |
|
| holding |
VRTX |
Common Stock |
|
|
|
|
|
140 |
01 Jul 2025 |
401(k) |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Stuart A. Arbuckle is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.